AmnioT1

Amnio Tek (ISP Surgical)

Introducing the new and innovative AmnioTek Processed Human Amniotic Membrane representing the latest in regenerative biologics technology for the ocular surface

About AmnioTek

AmnioT

AmnioTek graft

Introducing the new and innovative AmnioTek Processed Human Amniotic Membrane representing the latest in regenerative biologics technology for the ocular surface

Description

Viable

AMT has been successfully employed in the surgical treatment of the ocular surface in well over 100,000 cases over the past decade

AmnioTek offers the opthalmic surgeon an effective, natural, minimally processed dehydrated, device-like amniotic membrane tissue featuring anti-inflammatory and anti-adhesive properties ideal for wound covering and wound healing applications.

AmnioTek is a proven effective treatment for a host of ocular surface conditions.

Specification

Safety and sterility

AmnioTek amniotic tissue meets the most stringent donor screening and serological testing standards to ensure safety. AmnioTek is delivered sterile, dry and with a 3 year room-temperature shelf-life greatly reducing storage and shipping logistical costs incurred by other frozen allograft technologies.

Indications

Ophthalmic Indications

▪ Pterygium surgery

▪ Symblepharon release

▪ Dry eye

▪ Chemical burns

▪ Fornix formation

▪ Total LSCD

▪ Cicatrizing conjunctivitis

▪ Socket reconstruction

▪ PEDs

▪ Bullous keratopathy

▪ Conjunctivochalasis

▪ Partial LSCD

▪ Band keratopathy

▪ Entropion correction

▪ Non-healing stromal ulcers

Inherent properties of Amniotic Membrane

▪ Promotes and maintains epithelization

▪ Reduces inflammation

▪ Reduces scarring

▪ Anti-infective properties

▪ Reduces vascularisation